Literature DB >> 3998187

Clinical and histological features of delta infection in chronic hepatitis B virus carriers.

A S Lok, I Lindsay, P J Scheuer, H C Thomas.   

Abstract

One hundred and six consecutive chronic hepatitis B virus (HBV) carriers were studied for the prevalence of delta markers in serum and tissue, and the clinical and histological features of those with and without delta infection were compared. Twenty (18.9%) patients were positive for anti-delta in serum or delta antigen in the liver or both. They presented at a younger age (30.3 v 38 years). All of them were symptomatic at the time of biopsy, in contrast to 35% of patients without delta infection who were not symptomatic. Those with delta infection had higher serum transaminase values and showed more severe liver damage on biopsy: chronic active hepatitis in 45% and cirrhosis in 55%. There was more pronounced disease activity both within the parenchyma and in the portal and periportal zones. The histological diagnosis of the 86 patients without delta infection included minimal disease (10%), chronic persistent hepatitis (9%), chronic active hepatitis (62%), and cirrhosis (19%). Delta infection in chronic HBV carriers is associated with a more active and progressive liver disease.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3998187      PMCID: PMC499203          DOI: 10.1136/jcp.38.5.530

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  14 in total

1.  Cellular immunity and hepatitis-associated, Australia antigen liver disease.

Authors:  F J Dudley; R A Fox; S Sherlock
Journal:  Lancet       Date:  1972-04-01       Impact factor: 79.321

2.  U. K. prevalence of delta infection.

Authors:  R S Tedder; M Briggs; D R Howell
Journal:  Lancet       Date:  1982-10-02       Impact factor: 79.321

3.  Epidemiology of HBV-associated delta agent: geographical distribution of anti-delta and prevalence in polytransfused HBsAg carriers.

Authors:  M Rizzetto; R H Purcell; J L Gerin
Journal:  Lancet       Date:  1980-06-07       Impact factor: 79.321

4.  Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers.

Authors:  M Rizzetto; M G Canese; S Aricò; O Crivelli; C Trepo; F Bonino; G Verme
Journal:  Gut       Date:  1977-12       Impact factor: 23.059

5.  Inadequate antibody response to hBAg or suppressor T-cell defect in development of active chronic hepatitis.

Authors:  A L Eddleston; R Williams
Journal:  Lancet       Date:  1974-12-28       Impact factor: 79.321

6.  The early stages of absorption of injected horseradish peroxidase in the proximal tubules of mouse kidney: ultrastructural cytochemistry by a new technique.

Authors:  R C Graham; M J Karnovsky
Journal:  J Histochem Cytochem       Date:  1966-04       Impact factor: 2.479

7.  Multicentre study of prevalence of HBV-associated delta infection and liver disease in drug-addicts.

Authors:  G Raimondo; A Smedile; L Gallo; A Balbo; A Ponzetto; M Rizzetto
Journal:  Lancet       Date:  1982-01-30       Impact factor: 79.321

8.  Transmission of the hepatitis B virus-associated delta antigen to chimpanzees.

Authors:  M Rizzetto; M G Canese; J L Gerin; W T London; D L Sly; R H Purcell
Journal:  J Infect Dis       Date:  1980-05       Impact factor: 5.226

9.  Significance of delta agent infection in chronic hepatitis B virus infection: a study in British carriers.

Authors:  I V Weller; P Karayiannis; A S Lok; L Montano; M Bamber; H C Thomas; S Sherlock
Journal:  Gut       Date:  1983-11       Impact factor: 23.059

10.  The detection of HBV-DNA in serum by molecular hybridisation: a more sensitive method for the detection of complete HBV particles.

Authors:  I V Weller; M J Fowler; J Monjardino; H C Thomas
Journal:  J Med Virol       Date:  1982       Impact factor: 2.327

View more
  5 in total

1.  Correlation of hepatitis B virus, hepatitis D virus and human immunodeficiency virus type I infection markers in hepatitis B surface antigen positive haemophiliacs and patients without haemophilia with clinical and histopathological outcome of hepatitis.

Authors:  N Wagner; H W Rotthauwe; M Becker; H P Dienes; T Mertens; H J Födisch; H H Brackmann
Journal:  Eur J Pediatr       Date:  1992-02       Impact factor: 3.183

Review 2.  Delta and non-A, non-B hepatitis viruses.

Authors:  F Bonino; M Baldi; A Demartini
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-06       Impact factor: 3.267

Review 3.  Molecular hybridization techniques in current diagnosis of chronic hepatitis B in childhood.

Authors:  S Wirth; B Zabel
Journal:  Eur J Pediatr       Date:  1992-04       Impact factor: 3.183

4.  Prevalence and significance of intrahepatic hepatitis delta virus antigen expression in HBeAg-negative patients with chronic type-B hepatitis in Taiwan.

Authors:  C M Chu; W C Shyu; Y F Liaw
Journal:  Dig Dis Sci       Date:  1989-12       Impact factor: 3.199

5.  Prevalence of hepatitis delta antibody among HBsAG carriers in Saudi Arabia.

Authors:  Ibrahim Al-Traif; Amjad Ali; Mutasim Dafalla; Waleed Al-Tamimi; Leila Qassem
Journal:  Ann Saudi Med       Date:  2004 Sep-Oct       Impact factor: 1.526

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.